We are live on ! Find out more
CV

Clarus Ventures Portfolio holdings

AUM $425M
1-Year Est. Return 26.13%
This Fund
S&P 500
This Quarter Est. Return
-28%
1 Year Est. Return
+26.13%
3 Year Est. Return
+70.29%
5 Year Est. Return
+162.11%
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$22.4M
Cap. Flow
+$22.3M
Cap. Flow %
22.23%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
VERO
Venus Concept
VERO
+$22.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIEN
1
DELISTED
Sientra, Inc.
SIEN
$38.4M 38.22%
273,077
– –
NSTG
2
DELISTED
NanoString Technologies, Inc.
NSTG
$29.6M 29.44%
3,959,440
– –
VERO
3
DELISTED
Venus Concept
VERO
$16.4M 16.35%
+1,442
New +$22.3M
VBIV
4
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$11.5M 11.44%
89,701
– –
ATXS
5
DELISTED
Astria Therapeutics
ATXS
$4.1M 4.08%
45,875
– –
EPIX
6
DELISTED
ESSA Pharma
EPIX
$464K 0.46%
106,061
– –

Similar funds

LLC
Latimer Light Capital New York $432M AUM 25.5% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return
SPC
Salient Private Client Houston, Texas $513M AUM 10.97% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
CG
Clinton Group New York $279M AUM 4.76% 1-Year Est. Return
AAM
Amerigo Asset Management George Town, Cayman Islands $254M AUM 115.73% 1-Year Est. Return
SE
Summit Equities Parsippany, New Jersey $601M AUM 9.74% 1-Year Est. Return
CA
Cynosure Advisors Salt Lake City, Utah $238M AUM 4% 1-Year Est. Return

Clarus Ventures's Q4 2017 Portfolio in Review

As of Q4 2017, Clarus Ventures held 6 positions worth $100M, down 18% from $123M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Clarus Ventures deployed $22.3M of net new capital in Q4 2017, opening 1 new position. Its largest new stake was Venus Concept: 1,442 shares worth $16.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Clarus Ventures's largest Q4 2017 buy was Venus Concept: 1,442 shares worth $16.4M.
  • Clarus Ventures's ten largest holdings make up 100% of its $100M portfolio in Q4 2017.
  • Clarus Ventures opened 1 new position and closed 0 in Q4 2017.
  • Clarus Ventures's portfolio value fell 18% quarter-over-quarter to $100M.

Based on Clarus Ventures's 13F filing for Q4 2017, filed 12 Feb 2018.